Dermatitis: Clinical Trials

118 trials for Dermatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

118 completed. 118 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4118Completed 118

Follow Dermatitis: new trials by email Literature Review of Dermatitis trials Research Report on Dermatitis

Trials (filtered) newest first · largest first

All 118 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of 0.75% Piroctone Olamine Shampoo on the Hair and Scalp Microbiota of Hijab-Wearing Women With Seborrheic Dermatitis in Indonesia
Piroctone Olamine 0.75% Shampoo, Ketoconazole Shampoo, 2% - Seborrheic Dermatitis
Phase 4CompletedUniversitas Indonesia862026-01-122026-09-03
Topical Terbinafine Versus Hydrocortisone Combined With Oral Itraconazole for Seborrheic Dermatitis
Itraconazole, Terbinafine 1% cream, Hydrocortisone 1% cream - Seborrheic Dermatitis
Phase 4CompletedCan Tho University of Medicine and Pharmacy762025-07-072026-10-30
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden
Lebrikizumab - Atopic Dermatitis
Phase 4CompletedEli Lilly and Company2332025-06-162026-10-15
Skin Barrier Function and Inflammation in Aging: The BIA Study
CeraVe Moisturizing Cream, Vaseline - Inflammation, Skin Inflammation
Phase 4CompletedUniversity of California, San Francisco322025-02-062026-07-14
A Clinical Study to Assess the Efficacy and Safety of a Healing Ointment on Diaper Rash
"Cetaphil Healing Ointment" - Diaper Rash
Phase 4CompletedGalderma R&D262023-08-252026-05-12
Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis
Seysara Oral Product - Perioral Dermatitis
Phase 4CompletedThe Dermatology Institute of Boston92023-07-172024-06-21
Aquacel Hypersensitivity Dressing in TJAs
Aquacel dressing - Contact Allergic Dermatitis, Adverse Skin Reaction
Phase 4CompletedRush University Medical Center4572023-06-182026-08-04
A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis
Upadacitinib - Atopic Dermatitis
Phase 4CompletedAbbVie4612023-05-292025-07-29
Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic Dermatitis
Triamcinolone Acetonide (Aristocort® C), Vehicle - Atopic Dermatitis
Phase 4CompletedInnovaderm Research Inc.202023-05-092025-03-26
Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis
Dupilumab step-down - Atopic Dermatitis, Eczema, Atopic
Phase 4CompletedNantes University Hospital2562023-03-082026-09-24
Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China
Dupilumab - Atopic Dermatitis
Phase 4CompletedSanofi342023-02-222025-02-10
Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial
dupilumab, Topical emollient (moisturizer) - Moderate-to-Severe Atopic Dermatitis, Atopic Eczema
Phase 4CompletedRegeneron Pharmaceuticals1242023-01-112026-05-27
Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab
Abrocitinib - Atopic Dermatitis
Phase 4CompletedInnovaderm Research Inc.242022-11-252025-03-28
Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China
Dupilumab - Atopic Dermatitis, Dermatitis Atopic
Phase 4CompletedSanofi442022-11-252025-09-15
Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
Dupilumab, Vanicream- Dupilumab-naïve, Triamcinolone Acetonide - Atopic Dermatitis
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)4332022-11-212026-06-04
Tacrolimus Versus Hydrocortisone in Atopic Dermatitis
Tacrolimus, Hydrocortisone - Atopic, Dermatitis
Phase 4CompletedAin Shams University2002022-05-152023-07-24
Effects of Tildrakizumab on Epigenetic Age
TILDRAKIZUMAB - Psoriasis, Aging
Phase 4CompletedCarlos Wambier302022-04-082024-07-18
Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients
Olive oil cream, Betamethasone Valerate Cream, Base Cream - Radiodermatitis; Acute
Phase 4CompletedCairo University1322021-11-042025-02-12
Colloidal Oatmeal, Colloid Cream, Diaper Rash, Preterm Neonates and Neonatal Intensive Care Unit
Colloidal oatmeal, Cold cream - Diaper Rash, Preterm Neonates
Phase 4CompletedSeham El-Sayed Saleh Hassan902021-08-202023-09-22
Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis
Dupilumab (SAR231893) - Dermatitis Atopic
Phase 4CompletedSanofi542021-04-222025-09-16

Showing 20 of 118. Sign in to see all of them.

Narrower conditions

Dermatitis, Atopic (87)  ·  Eczema (19)  ·  Dermatitis, Seborrheic (6)  ·  Diaper Rash (5)  ·  Psoriasis (5)  ·  Pruritus (4)  ·  Dermatitis, Allergic Contact (3)  ·  Tinea Cruris (3)  ·  Tinea Pedis (3)  ·  Asthma (2)  ·  Bronchiolitis Obliterans Syndrome (2)  ·  Facies (2)  ·  Inflammation (2)  ·  Lymphoma, Follicular (2)

Broader conditions

Skin and Connective Tissue Diseases (118)  ·  Skin Diseases (117)  ·  Skin Diseases, Eczematous (107)  ·  Immune System Diseases (93)  ·  Hypersensitivity (92)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (87)  ·  Genetic Diseases, Inborn (87)  ·  Hypersensitivity, Immediate (87)  ·  Skin Diseases, Genetic (87)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Skin Diseases, Papulosquamous (12)  ·  Dermatitis, Contact (7)  ·  Sebaceous Gland Diseases (7)  ·  Signs and Symptoms (7)

Interventions

pimecrolimus (18)  ·  Tacrolimus (12)  ·  dupilumab (11)  ·  crisaborole (5)  ·  Petrolatum (4)  ·  Adrenal Cortex Hormones (3)  ·  Hydrocortisone (3)  ·  Omalizumab (3)  ·  montelukast (3)  ·  Fluocinonide (2)  ·  Fluticasone (2)  ·  Saline Solution (2)  ·  Sodium Chloride (2)  ·  Triamcinolone Acetonide (2)  ·  methylprednisolone aceponate (2)

Sponsors

Novartis (10)  ·  Astellas Pharma Inc (7)  ·  Sanofi (6)  ·  Stiefel, a GSK Company (4)  ·  Derm Research, PLLC (3)  ·  Innovaderm Research Inc. (3)  ·  University of California, San Francisco (3)  ·  Wake Forest University (3)  ·  Wake Forest University Health Sciences (3)  ·  Allerderm (2)  ·  Bayer (2)  ·  Casa Espirita Terra de Ismael (2)  ·  Ceragenix Pharmaceuticals (2)  ·  Fougera Pharmaceuticals Inc. (2)  ·  Janssen-Cilag Ltd.,Thailand (2)

Countries

United States (62)  ·  Germany (9)  ·  Canada (8)  ·  United Kingdom (6)  ·  Brazil (5)  ·  Australia (4)  ·  China (4)  ·  France (4)  ·  Switzerland (4)  ·  Belgium (3)  ·  Dominican Republic (3)  ·  Egypt (3)  ·  Finland (3)  ·  Spain (3)  ·  Vietnam (3)

Top investigators

Robert Bissonnette, MD (3)  ·  Alan Fleischer, MD (2)  ·  Anya Loncaric (2)  ·  Leon H. Kircik, M.D. (2)

Results publications

PMID 19127072, PMID 19403473, PMID 19863501, PMID 21099191, PMID 21121981, PMID 21533301, PMID 22134563, PMID 23377341, PMID 23388687, PMID 23545917, PMID 23675632, PMID 24435467, PMID 28330497, PMID 28491950, PMID 31764962, PMID 32212104, PMID 33760691, PMID 36824052, PMID 37181420, PMID 37799965, PMID 40973558, PMID 41350756, PMID 41611123, PMID 42027418, PMID 42126851, PMID 42617697

NIH funding

2004 (1), 2018 (1), R21AR082620 (1)